EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of definitive chemoradiotherapy for laryngeal squamous cell carcinoma: A single-center experience

Asma Daneshvar, Candan Abakay, Meral Kurt, Sibel Çetintaş

Radiation Sciences in Oncology · 2026

DOI: 10.33066/rso.2026.23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Sciences in Oncology, 2026. Verfasst von Asma Daneshvar und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Definitive chemoradiotherapy (CRT) is an established organ-preservation strategy for laryngeal squamous cell carcinoma (LSCC). However, real-world data regarding long-term survival and prognostic factors remain limited. This study evaluated survival outcomes, prognostic factors in LSCC patients treated with definitive nonsurgical therapy. Materials and Methods: In this retrospective study, 68 patients with pathologically confirmed stage II–IVA LSCC treated with definitive CRT between 2010 and 2022 were analyzed. Forty patients (58.8%) received induction chemotherapy followed by concurrent CRT, while 28 (41.2%) received upfront concurrent CRT. Recurrence-free survival (RFS), disease-free survival (DFS), metastasis-free survival (MFS), and overall survival (OS) were estimated using the Kaplan–Meier method. Prognostic factors were evaluated using univariable Cox regression models.

Results

The median follow-up was 27.4 months. Three-year survival rates were: RFS 77.6% (95% CI, 66.6%–88.6%), DFS 76.3% (95% CI, 65.1%–87.5%), MFS 94.4% (95% CI, 88.1%–100%), and OS 62.9% (95% CI, 50.4%–75.4%). Univariable analysis revealed no significant association between survival outcomes and age, sex, stage, induction chemotherapy, RT technique, SUVmax, or RT duration. Stratified by RT duration (≤ 51 vs. > 51 days), RT duration did not significantly affect RFS in upfront CRT patients (70.7% vs. 66.7%; p = 0.160). However, in patients receiving induction chemotherapy followed by CRT, prolonged RT duration (> 51 days) showed a trend toward poorer 3-year RFS (53.7% vs. 62.9%; p = 0.077). Grade 3–4 toxicities included dysphagia (14.7%), hematologic toxicity (11.8%), and xerostomia (4.4%). Ten patients underwent salvage total laryngectomy during follow-up.

Conclusions

Definitive nonsurgical therapy provided satisfactory disease control in LSCC. Although overall RT duration was not significantly associated with survival across the cohort, prolonged RT duration following induction chemotherapy showed a trend toward inferior RFS, highlighting the importance of avoiding treatment delays after induction therapy.

Zitieren

APA

Daneshvar, A., Abakay, C., Kurt, M., & Çetintaş, S. (2026). Outcomes of definitive chemoradiotherapy for laryngeal squamous cell carcinoma: A single-center experience. Radiation Sciences in Oncology. https://doi.org/10.33066/rso.2026.23

Vancouver

Daneshvar A, Abakay C, Kurt M, Çetintaş S. Outcomes of definitive chemoradiotherapy for laryngeal squamous cell carcinoma: A single-center experience. Radiation Sciences in Oncology. 2026. doi:10.33066/rso.2026.23

BibTeX
@article{Daneshvar2026,
  author = {Daneshvar, Asma and Abakay, Candan and Kurt, Meral and Çetintaş, Sibel},
  title = {Outcomes of definitive chemoradiotherapy for laryngeal squamous cell carcinoma: A single-center experience},
  journal = {Radiation Sciences in Oncology},
  year = {2026},
  doi = {10.33066/rso.2026.23}
}
Kostenlos starten →